Rhythm Biosciences Ltd has released a press release.
Initial TGA Regulatory Documentation Submitted
Filed with ASX ·
6ix hasn’t read this filing yet.
Rhythm Biosciences Limited on 6ix
Earlier from Rhythm Biosciences
- Non Renounceable pro rata offer - Completion of despatch
- Rights Issue Investor Presentation
- Non renouneable rights issue prospectus
- Rhythm Establishes US Entity To Drive US Expansion Strategy
- Rhythm to Present at MST Access Investor Conference
Later from Rhythm Biosciences
- Rhythm Completes Strongly Oversubscribed $4.3M Rights Issue
- TGA Accepts Initial Regulatory Documentation
- Rhythm Completes Recruitment for Clinical Trial (Study 7)
- Rhythm Receives $2.4m R&D Tax Incentive
- ColoSTAT Test Kits Deliver Consistent, High Accuracy Results
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences